Simplex Trading
EW icon

Simplex Trading’s Edwards Lifesciences EW Stock Holding History

Simplex Trading’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.59M Sell
32,300
-45,400
-58% -$3.74M ﹤0.01% 1608
2025
Q4 		$6.62M Sell
77,700
-80,100
-51% -$6.57M ﹤0.01% 1092
2025
Q3 		$12.3M Buy
157,800
+48,000
+44% +$3.75M 0.01% 846
2025
Q2 		$8.59M Sell
109,800
-169,500
-61% -$12.6M ﹤0.01% 987
2025
Q1 		$20.2M Sell
279,300
-56,200
-17% -$4.02M 0.01% 517
2024
Q4 		$24.8M Sell
335,500
-5,200
-2% -$364K 0.01% 524
2024
Q3 		$22.5M Buy
340,700
+152,900
+81% +$11.1M 0.01% 595
2024
Q2 		$17.3M Buy
187,800
+4,800
+3% +$425K 0.01% 688
2024
Q1 		$17.5M Sell
183,000
-86,300
-32% -$7.25M 0.01% 782
2023
Q4 		$20.5M Sell
269,300
-83,700
-24% -$5.82M 0.01% 714
2023
Q3 		$24.5M Buy
353,000
+235,400
+200% +$18.9M 0.02% 498
2023
Q2 		$11.1M Sell
117,600
-148,500
-56% -$12.9M 0.01% 838
2023
Q1 		$22M Sell
266,100
-4,500
-2% -$354K 0.02% 551
2022
Q4 		$20.2M Buy
270,600
+210,200
+348% +$16.2M 0.02% 554
2022
Q3 		$4.99M Sell
60,400
-5,500
-8% -$529K 0.01% 1213
2022
Q2 		$6.27M Buy
65,900
+5,200
+9% +$538K 0.01% 1021
2022
Q1 		$7.14M Buy
60,700
+24,500
+68% +$2.75M 0.01% 1022
2021
Q4 		$4.69M Buy
36,200
+1,100
+3% +$128K ﹤0.01% 1257
2021
Q3 		$3.68M Sell
35,100
-5,300
-13% -$605K ﹤0.01% 1481
2021
Q2 		$4.18M Buy
40,400
+40,112
+13,928% +$3.78M ﹤0.01% 1349
2021
Q1 		$2.41M Buy
+288
New +$24.3K ﹤0.01% 1420
2020
Q4 		– Sell
-1,097
Closed -$8.76M – 8529
2020
Q3 		$8.76M Sell
1,097
-142
-11% -$11.1K 0.01% 574
2020
Q2 		$8.56M Buy
1,239
+684
+123% +$48.6K 0.01% 578
2020
Q1 		$3.49M Sell
555
-516
-48% -$37.2K 0.01% 900
2019
Q4 		$8.33M Sell
1,071
-120
-10% -$9.37K 0.02% 538
2019
Q3 		$8.73M Buy
1,191
+609
+105% +$42.8K 0.02% 464
2019
Q2 		$3.58M Sell
582
-957
-62% -$57.9K 0.01% 891
2019
Q1 		$9.81M Buy
1,539
+858
+126% +$49K 0.03% 401
2018
Q4 		$3.48M Sell
681
-270
-28% -$13.7K 0.01% 754
2018
Q3 		$5.52M Buy
951
+327
+52% +$16K 0.02% 568
2018
Q2 		$3.03M Buy
624
+435
+230% +$20.3K 0.01% 846
2018
Q1 		$88K Sell
189
-534
-74% -$23.2K ﹤0.01% 1901
2017
Q4 		$61K Sell
723
-336
-32% -$12.3K ﹤0.01% 2247
2017
Q3 		$21K Buy
1,059
+390
+58% +$14.9K ﹤0.01% 3097
2017
Q2 		$48K Sell
669
-30
-4% -$1.09K ﹤0.01% 2434
2017
Q1 		$41K Sell
699
-105
-13% -$3.29K ﹤0.01% 2553
2016
Q4 		$36K Sell
804
-93
-10% -$3.01K ﹤0.01% 2470
2016
Q3 		$293K Buy
897
+87
+11% +$3.28K 0.02% 791
2016
Q2 		$139K Buy
810
+204
+34% +$6.98K 0.01% 1242
2016
Q1 		$76K Sell
606
-39
-6% -$1.08K 0.01% 1575
2015
Q4 		$34K Sell
645
-807
-56% -$21K ﹤0.01% 2237
2015
Q3 		$145K Buy
1,452
+912
+169% +$22K 0.01% 1125
2015
Q2 		$60K Buy
540
+336
+165% +$7.58K 0.01% 1556
2015
Q1 		$6K Sell
204
-354
-63% -$7.94K ﹤0.01% 3337
2014
Q4 		$162K Buy
+558
New +$11.2K 0.02% 703

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Simplex Trading's EW Position: Q3 2025 in Review

Simplex Trading sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 9,510 shares — an estimated $743K sold.

Simplex Trading first reported a position in EW in Q4 2014 and held it in 25 quarters. The position peaked at $6.12M in Q1 2024. 1,253 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • Simplex Trading reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 9,510 Edwards Lifesciences shares in Q3 2025, an estimated $743K.
  • Simplex Trading first reported a position in Edwards Lifesciences in Q4 2014 and held it in 25 quarters.
  • Simplex Trading's Edwards Lifesciences position peaked at $6.12M in Q1 2024.
  • 1,253 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.